A cost-effectiveness evaluation of methods for screening for TB infection in patients with diabetes mellitus

Despite its higher initial cost, QFT-plus is both more economical and clinically superior to TST in the context of Malaysia's high prevalence of DM. This underscores the need for its broader adoption through policy shifts to incorporate QFT-plus into national guidelines. Future research should address implementation and broader socio-economic aspects.